Login / Signup

The landscape of antibody binding in SARS-CoV-2 infection.

Anna S HeffronSean J McIlwainMaya F AmjadiDavid A BakerSaniya KhullarAjay K SethiAnn C PalmenbergMiriam A ShelefDavid H O'ConnorIrene M Ong
Published in: bioRxiv : the preprint server for biology (2021)
The search for potential antibody-based diagnostics, vaccines, and therapeutics for pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has focused almost exclusively on the spike (S) and nucleocapsid (N) proteins. Coronavirus membrane (M), ORF3a, and ORF8 proteins are humoral immunogens in other coronaviruses (CoVs) but remain largely uninvestigated for SARS-CoV-2. Here we use ultradense peptide microarray mapping to show that SARS-CoV-2 infection induces robust antibody responses to epitopes throughout the SARS-CoV-2 proteome, particularly in M, in which one epitope achieved excellent diagnostic accuracy. We map 79 B cell epitopes throughout the SARS-CoV-2 proteome and demonstrate that antibodies that develop in response to SARS-CoV-2 infection bind homologous peptide sequences in the six other known human CoVs. We also confirm reactivity against four of our top-ranking epitopes by enzyme-linked immunosorbent assay (ELISA). Illness severity correlated with increased reactivity to nine SARS-CoV-2 epitopes in S, M, N, and ORF3a in our population. Our results demonstrate previously unknown, highly reactive B cell epitopes throughout the full proteome of SARS-CoV-2 and other CoV proteins.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • coronavirus disease
  • endothelial cells
  • small molecule
  • high throughput
  • mass spectrometry
  • dna repair
  • binding protein